Next-generation encoded chemical libraries for drug discovery
The construction and screening of very large chemical libraries is the basis of small molecule drug discovery. We will construct large DNA-encoded libraries of unprecedented quality by implementing proprietary technologies and by capitalizing on high-value building blocks, which will be shared by the two companies. Philochem will construct single- and dual-pharmacophore libraries, while Vipergen will use YoctoReactor™ technology for the synthesis of libraries based on 3 sets of building blocks.
1 928 000.00€